Edit
Chondrial Therapeutics, Inc.
http://www.chondrialtherapeutics.com/Last activity: 22.05.2019
Active - Reference to Larimar Therapeutics Inc.
Employees: 11-50
Total raised: $48.4M
Founded date: 2013
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.05.2019 | - | $25.8M | - |
| 07.02.2017 | Series A | $22.6M | Deerfield ... |
Mentions in press and media 6
| Date | Title | Description |
| 22.05.2019 | Biotech company Chondrial Therapeutics has raised $25.8M for its Friedreich’s ataxia treatment | Eleven-person biotech company Chondrial Therapeutics just raised $25.8 million in a private stock sale to commercialize its treatment for people with the neurodegenerative movement disorder Friedreich’s ataxia. The funding will support Chon... |
| 22.05.2019 | Chondrial Therapeutics Raises $25.8M for its Friedreich’s Ataxia Treatment | Eleven-person biotech company Chondrial Therapeutics just raised $25.8 million in a private stock sale to commercialize its treatment for people with the neurodegenerative movement disorder Friedreich’s ataxia. The funding will support Chon... |
| 22.05.2019 | Chondrial Therapeutics Raises $25.8M for its Friedreich’s Ataxia Treatment | Eleven-person biotech company Chondrial Therapeutics just raised $25.8 million in a private stock sale to commercialize its treatment for people with the neurodegenerative movement disorder Friedreich’s ataxia. The funding will support Chon... |
| 06.02.2017 | Chondrial Therapeutics Raises $22.6 Million | Chondrial Therapeutics, Inc., an emerging biotechnology company focused on the treatment of rare mitochondrial diseases, announced today that it has secured up to $22.6 million in Series A financing led by Deerfield Management and has appoi... |
| 06.02.2017 | Deerfield Leads $22.6M Series A for Chondrial Therapeutics | Chondrial Therapeutics, Inc., an emerging biotechnology company focused on the treatment of rare mitochondrial diseases, announced today that it has secured up to $22.6 million in Series A financing led by Deerfield Management and has appoi... |
| 06.02.2017 | Chondrial Therapeutics Secures up to $22.6M in Series A Financing | Chondrial Therapeutics, Inc., a Bala Cynwyd, PA-based biotechnology company focused on the treatment of rare mitochondrial diseases, secured up to $22.6m in Series A financing. The round was led by Deerfield Management. Led by newly appoint... |